Clinical trials in Clermont Ferrand – page 55

Innovative studies focusing on inflammatory bowel diseases including groundbreaking trials examining fecal microbiota transplantation in both Crohn's disease and ulcerative colitis. Research aims to evaluate new therapeutic approaches for patients with moderate to severe conditions.

• Crohn's Disease Management
• Ulcerative Colitis Treatment
• Microbiota-based Therapies

These trials are exploring alternative treatment pathways for patients who have not responded to conventional therapies.

Comprehensive research in multiple myeloma and various cancer types, including innovative treatments for esophageal squamous cell carcinoma and pleural mesothelioma. Studies evaluate new therapeutic combinations and maintenance strategies.

• Blood Cancer Treatments
• Prostate Cancer Therapy
• Biliary Tract Cancer Research

Focus on improving patient outcomes through targeted therapies and immunological approaches.

Advanced research into rheumatoid arthritis and multiple sclerosis, investigating optimized treatment protocols and maintenance therapies. Studies aim to improve long-term disease management and patient quality of life.

• Multiple Sclerosis Treatments
• Rituximab Optimization
• Antibody-based Therapies

Emphasis on developing more effective and tolerable treatment regimens.